Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM18N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,865
Award facts
- Contract value 100% obligated
- $68,864.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $68,864.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio under the SPE2DX global contract vehicle, which enables the company to fulfill federal medical supply needs across multiple therapeutic domains. Dupixent (dupilumab) is a specialty biologic medication used to treat conditions including moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps. The award reflects AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and its established role as a primary pharmaceutical distributor supporting Defense Health Agency customers and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FM18N?
SPE2DR26FM18N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FM18N worth?
The government has obligated $68,865 on SPE2DR26FM18N.
Is contract SPE2DR26FM18N an order under another contract?
Yes. SPE2DR26FM18N is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM18N competed?
The extent of competition for SPE2DR26FM18N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award